HBM+ is excited to share the third annual Drug Trends and Strategic Insights report, which highlights the drug claims and utilization data we administer on behalf of our partners. This year’s report provides the updates you are accustomed to seeing on trends tied to specialty drugs, biologics and biosimilars, as well as the impacts of new, costlier, chronic disease therapies. The report also builds upon last year’s update related to the growing use of digital pharmacy services.
As COVID-19 still poses a challenge, especially with new and emerging variants of concern, we have introduced a section on the COVID-19-related therapies being introduced to combat the virus. Shifting to future trends and the pipeline of new drug therapies, an addition to this year’s report is a deep dive on three drug classes that are seeing significant growth in terms of claimants and costs: diabetes, obesity, and cystic fibrosis.
2022: Drug trends & strategic insights report
September 22, 2022
Cares
The Current State of Women’s Mental Health in Canada
Take control of your mental health. Canadian women, particularly those from marginalized and racialized communities, are neglecting their well-being. Learn about the lasting consequences and barriers they face. Start your journey to self-care today.
Read more
Cares
What is internet-based Cognitive Behavioural Therapy (Digital CBT) and how can it help you?
Discover the transformative power of iCBT for mental wellness. Overcome barriers to care with online Cognitive Behavioural Therapy. Sign up for free today!
Read more
Cares
You’re not broken, you’re human: Tips and tools that helped me manage my mental health
Take the first step towards healing and self-empowerment. Our therapy services cater specifically to South Asian women, offering a safe and understanding environment. Break free from the stigma surrounding mental health and embrace the support you need to thrive.
Read more